The involvement of β-actin in the signaling of transmembrane TNF-α-mediated cytotoxicity

Journal of Leukocyte Biology

Volumn 89, Issue 6, 2011, Pages 917-926

  Chen, Hui ^a   Xiao, Li ^a   Zhang, Hailong ^a   Liu, Na ^a   Liu, Tao ^a   Liu, Lili ^a   Hu, Xin ^a   Yan, Dan ^a   Yang, Kun ^a   Yin, Bingjiao ^a   Wang, Jing ^a   Li, Qingfen ^a   Li, Zhuoya ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Cytoskeleton; Tnfr; Tnfr2; Tumor

Indexed keywords

BETA ACTIN; CASPASE 8; CYTOCHALASIN D; FLICE INHIBITORY PROTEIN; I KAPPA B; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

ACTIN POLYMERIZATION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION;

ACTINS; ANIMALS; APOPTOSIS; BICYCLO COMPOUNDS, HETEROCYCLIC; BLOTTING, WESTERN; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CELL MEMBRANE; CYTOCHALASIN D; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HL-60 CELLS; HUMANS; I-KAPPA B PROTEINS; IMMUNOPRECIPITATION; INTERLEUKIN-8; MICE; NF-KAPPA B; NIH 3T3 CELLS; NUCLEAR PORE COMPLEX PROTEINS; NUCLEIC ACID SYNTHESIS INHIBITORS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; THIAZOLIDINES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79957837396     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1209812     Document Type: Article

References (57)

1. Tracey, K. J., Cerami, A. (1993) Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 9, 317-343.
2. Vandenabeele, P., Declercq, W., Beyaert, R., Fiers, W. (1995) Two tumor necrosis factor receptors: structure and function. Trends Cell Biol. 5, 392-399.
3. Luettig, B., Decker, T., Lohmann-Matthes, M. L. (1989) Evidence for the existence of two forms of membrane tumor necrosis factor: an integral protein and a molecule attached to its receptor. J. Immunol. 143, 4034-4038.
4. Aversa, G., Punnonen, J., de Vries, J. E. (1993) The 26-kD transmembrane form of tumor necrosis factor a on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation. J. Exp. Med. 177, 1575-1585.
5. Parry, S. L., Sebbag, M., Feldmann, M., Brennan, F. M. (1997) Contact with T cells modulates monocyte IL-10 production: role of T cell membrane TNF-α. J. Immunol. 158, 3673-3681.
6. Burger, D., Lou, J., Dayer, J. M., Grau, G. E. (1997) Both soluble and membrane-associated TNF activate brain microvascular endothelium: relevance to multiple sclerosis. Mol. Psychiatry 2, 113-116.
7. Peck, R., Brockhaus, M., Frey, J. R. (1989) Cell surface tumor necrosis factor (TNF) accounts for monocyte- and lymphocyte-mediated killing of TNF-resistant target cells. Cell. Immunol. 122, 1-10.
8. Shi, W., Li, Z., Gong, F. (1998) Comparison of the cytocidal effect induced by transmembrane and secreted TNF-α. Chin. J. Microbiol. Immunol. 18, 499 -504.
9. Heller, R. A., Song, K, Fan, N., Chang, D.J. (1992) The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 70, 47-56.
10. Reid, T., Louie, P., Heller, R A. (1994) Mechanisms of tumor necrosis factor cytotoxicity and the cytotoxic signals transduced by the p75-tumor necrosis factor receptor. Circ. Shock 44, 84-90.
11. Grell, M., Douni, E., Wajant, H, Lohden, M., Clauss, M., Maxeiner, B., Georgo-poulos, S., Lesslauer, W., Kollias, G, Pfizenmaier, K, Scheurich, P. (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83, 793-802.
12. Prendergast, G. C. (2001) Actin' up: RhoB in cancer and apoptosis. Nat. Rev. Cancer 1, 162-168.
13. Shive, M. S., Brodbeck, W. G., Colton, E., Anderson, J. M. (2002) Shear stress and material surface effects on adherent human monocyte apoptosis. J. Biomed. Mater. Res. 60, 148-158.
14. Mashima, T., Naito, M., Fujita, N., Noguchi, K, Tsuruo, T. (1995) Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. Biochem. Biophys. Res. Commun. 217, 1185-1192.
15. Cabado, A. G., Leira, F., Vieytes, M. R, Vieites, J. M., Botana, L. M. (2004) Cytoskeletal disruption is the key factor that triggers apoptosis in okadaic acid-treated neuroblastoma cells. Arch. Toxicol. 78, 74-85.
16. Parlato, S., Giammarioli, A M., Logozzi, M., Lozupone, F., Matarrese, P., Lu-ciani, F., Falchi, M., Malorni, W., Fais, S. (2000) CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBOJ. 19, 5123-5134.
17. Algeciras-Schimnich, A, Shen, L., Barnhart, B. C, Murmann, A. E., Burkhardt, J. K, Peter, M. E. (2002) Molecular ordering of the initial signaling events of CD95. Mol. Cell. Biol. 22, 207-220.
18. Domnina, L. V., Ivanova, O. Y., Cherniak, B. V., Skulachev, V. P., Vasiliev, J. M. (2002) Effects of the inhibitors of dynamics of cytoskeletal structures on the development of apoptosis induced by the tumor necrosis factor. Biochemistry (Mosc.) 67, 737-746.
19. Li, J., Li, Q., Xie, C, Zhou, H., Wang, Y., Zhang, N., Shao, H., Chan, S. C., Peng, X., Lin, S. C, Han, J. (2004) β-Actin is required for mitochondria clustering and ROS generation in TNF-induced, caspase-inde-pendent cell death. J. Cell Sci. 117, 4673-4680.
20. Peck, R., Brockhaus, M., Frey, J. R (1991) The principal tumor necrosis factor receptor in monocyte cytotoxicity is on the effector cell, not on the target cell. Cell. Immunol. 132, 308-318.
21. Li, Q., Li, L., Li, Z., Gong, F., Feng, W., Jiang, X., Xiong, P. (2002) Antitumor effects of the fibroblasts transfected TNF-α gene and its mutants. J. Huazhong Univ. Sci. Technolog. Med. Sci. 22, 92-95.
22. Mazur, L., Augustynek, A, Bochenek, M. (2002) Flow cytometric estimation of the plasma membrane diversity of bone marrow cells in mice treated with WR-2721 and cyclophosphamide. Toxicology 171, 63-72.
23. Ye, F., Li, Z., Yin, B., Gong, F., Jiang, X., Feng, W., Xu, Y, Xiong, P. (2002) The expression and activity of human soluble TNF receptor I by E. coli and appraisement of its activity. Chin. J. Immunol. 18, 743-746.
24. Liang, H., Li, Q., Chen, Q., Jiang, X., Feng, W., Li, Z. (2005) Cloning and expression of human soluble tumor necrosis factor receptor II by E. coli and appraisement of its activity. J. Huazhong Univ. Sci. Technolog. Med. Sci. 34, 536-538.
25. Jin, S., Lu, D., Ye, S., Ye, H., Zhu, L., Feng, Z., Liu, S., Wang, D., Hu, Q. (2005) A simplified probe preparation for ELISA-based NF-kB activity assay. J. Biochem. Biophys. Methods 65, 20-29.
26. Sympson, C. J., Geoghegan, T E. (1990) Actin gene expression in murine eryth-roleukemia cells treated with cytochalasin D. Exp. Cell Res. 189, 28-32.
27. Grech, A. P., Gardam, S., Chan, T., Quinn, R, Gonzales, R, Basten, A, Brink, R (2005) Tumor necrosis factor receptor 2 (TNFR2) signaling is negatively regulated by a novel, carboxyl-terminal TNFR-associated factor 2 (TRAF2)-binding site. J. Biol. Chem. 280, 31572-31581.
28. Devin, A, Cook, A, Lin, Y, Rodriguez, Y, Kelliher, M., Liu, Z. (2000) The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12, 419-429.
29. Takeuchi, M., Rothe, M., Goeddel, D. V. (1996) Anatomy of TRAF2. Distinct domains for nuclear factor-KB activation and association with tumor necrosis factor signaling proteins. J. Biol. Chem. 271, 19935-19942.
30. Devin, A, Lin, Y, Yamaoka, S., Li, Z., Karin, M., Liu, Z. (2001) The a and β subunits of IkB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF. Mol. Cell. Biol. 21, 3986-3994.
31. Steube, K. G., Meyer, C, Drexler, H. G. (2000) Multiple regulation of constitutive and induced interleukin 8 secretion in human myelomono-cytic cell lines. Cytokine 12, 1236-1239.
32. Lin, Y, Devin, A., Rodriguez, Y, Liu, Z. G. (1999) Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev. 13, 2514-2526.
33. Watsky, M. A, Guan, Z., Ragsdale, D. N. (1996) Effect of tumor necrosis factor a on rabbit corneal endothelial permeability. Invest. Ophthalmol. Vis. Sci. 37, 1924-1929.
34. Kutsuna, H., Suzuki, K, Kamata, N, Kato, T, Hato, F., Mizuno, K, Kobayashi, H., Ishii, M., Kitagawa, S. (2004) Actin reorganization and morphological changes in human neutrophils stimulated by TNF, GM-CSF, and G-CSF: the role of MAP kinases. Am J. Physiol Cell Physiol. 286, C55-C64.
35. Tsakiridis, T., Tong, P., Matthews, B., Tsiani, E., Bilan, P. J., Klip, A., Downey, G. P. (1999) Role of the actin cytoskeleton in insulin action. Microsc. Res. Tech. 47, 79-92.
36. Takeda, T. (2003) Podocyte cytoskeleton is connected to the integral membrane protein podocalyxin through Na+/H+-exchanger regulatory factor 2 and ezrin. Clin. Exp. Nephrol. 7, 260-269.
37. Cox, B. D., Natarajan, M., Stettner, M. R, Gladson, C. L. (2006) New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. J. Cell. Biochem. 99, 35-52.
38. Xu, J., Chakrabarti, A. K, Tan, J. L., Ge, L., Gambotto, A, Vujanovic, N. L. (2007) Essential role of the TNF-TNFR2 cognate interaction in mouse dendritic cell-natural killer cell crosstalk. Blood 109, 3333-3341.
39. Shi, W., Li, Z., Gong, F. (1998) A comparison between the effects of transmembrane and secretory tumor necrosis factor-a on tumor necrosis factor receptors. Chin. J. Immunol. 14, 243-246.
40. Schutze, S., Machleidt, T., Adam, D., Schwandner, R, Wiegmann, K, Kruse, M. L., Heinrich, M., Wickel, M., Kronke, M. (1999) Inhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signaling. J. Biol. Chem. 274, 10203-10212.
41. Rothe, M., Wong, S. C, Henzel, W. J., Goeddel, D. V. (1994) A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681-692.
42. Pimentel-Muiños, F. X., Seed, B. (1999) Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. Immunity 11, 783-793.
43. Zhang, H., Yan, D., Shi, X., Liang, H., Pang, Y, Qin, N., Chen, H., Wang, J., Yin, B., Jiang, X., Feng, W., Zhang, W., Zhou, M., Li, Z. (2008) Transmembrane TNF-α mediates forward and reverse signaling, inducing cell death or survival via the NF-kB pathway in Raji Burkitt lymphoma cells. J. Leukoc. Biol. 84, 789-797.
44. Baeuerle, P. A, Baltimore, D. (1996) NF-k B: ten years after. Cell 87, 13-20.
45. Baldwin Jr., A. S. (1996) The NF-k B and IkB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683.
46. Kitahara, J., Sakamoto, H., Tsujimoto, M., Nakagawa, Y (2000) Involvement of NF-kB in the protection of cell death by tumor necrosis factor in L929 derived TNF resistant C12 cells. Biol. Pharm. Bull. 23, 397-401.
47. Kustermans, G, El Mjiyad, N, Horion, J., Jacobs, N, Piette, J., Legrand-Poels, S. (2008) Actin cytoskeleton differentially modulates NF-KB-mediated IL-8 expression in myelomonocytic cells. Biochem. Pharmacol 76, 1214-1228.
48. Papakonstanti, E. A, Stournaras, C. (2004) Tumor necrosis factor-a promotes survival of opossum kidney cells via Cdc42-induced phospholipase C-71 activation and actin filament redistribution. Mol. Biol. Cell 15, 1273-1286.
49. Rothe, M., Sarma, V., Dixit, V. M., Goeddel, D. V. (1995) TRAF2-mediated activation of NF-k B by TNF receptor 2 and CD40. Science 269, 1424-1427.
50. Baud, V., Liu, Z. G., Bennett, B., Suzuki, N., Xia, Y, Karin, M. (1999) Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev. 13, 1297-1308.
51. Hsu, H., Huang, J., Shu, H. B., Baichwal, V., Goeddel, D. V. (1996) TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387-396.
52. Kelliher, M. A, Grimm, S., Ishida, Y, Kuo, F., Stanger, B. Z., Leder, P. (1998) The death domain kinase RIP mediates the TNF-induced NF-kB signal. Immunity 8, 297-303.
53. Lee, T. H., Shank, J., Cusson, N., Kelliher, M. A. (2004) The kinase activity of Rip1 is not required for tumor necrosis factor-a-induced IkB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2. J. Biol. Chem. 279, 33185-33191.
54. Li, H., Kobayashi, M., Blonska, M., You, Y, Lin, X. (2006) Ubiquitination of RIP is required for tumor necrosis factor a-induced NF-kB activation. J. Biol. Chem. 281, 13636-13643.
55. Park, S. J., Kim, Y Y, Ju, J. W., Han, B. G., Park, S. I., Park, B. J. (2001) Alternative splicing variants of c-FLIP transduce the differential signal through the Raf or TRAF2 in TNF-induced cell proliferation. Biochem. Biophys. Res. Commun. 289, 1205-1210.
56. Kataoka, T., Budd, R C, Holler, N., Thome, M., Martinon, F., Irmler, M., Burns, K, Hahne, M., Kennedy, N., Kovacsovics, M., Tschopp, J. (2000) The caspase-8 inhibitor FLIP promotes activation of NF-kB and Erk signaling pathways. Curr. Biol. 10, 640-648.
57. Srinivasula, S. M., Saleh, A, Ahmad, M., Fernandes-Alnemri, T., Alnemri, E. S. (2001) Isolation and assay of caspases. Methods Cell Biol. 66, 1-27.